BCG-induced cross-protection and development of trained immunity: implication for vaccine design

C Covián, A Fernández-Fierro, A Retamal-Díaz… - Frontiers in …, 2019 - frontiersin.org
The Bacillus Calmette-Guérin (BCG) is a live attenuated tuberculosis vaccine that has the
ability to induce non-specific cross-protection against pathogens that might be unrelated to …

The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis

R Kalscheuer, A Palacios, I Anso, J Cifuente… - Biochemical …, 2019 - portlandpress.com
Bacterial capsules have evolved to be at the forefront of the cell envelope, making them an
essential element of bacterial biology. Efforts to understand the Mycobacterium tuberculosis …

[HTML][HTML] A functional role for antibodies in tuberculosis

LL Lu, AW Chung, TR Rosebrock, M Ghebremichael… - Cell, 2016 - cell.com
While a third of the world carries the burden of tuberculosis, disease control has been
hindered by a lack of tools, including a rapid, point-of-care diagnostic and a protective …

Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques

K Dijkman, CC Sombroek, RAW Vervenne… - Nature medicine, 2019 - nature.com
Tuberculosis (TB) remains the deadliest infectious disease, and the widely used Bacillus
Calmette–Guérin (BCG) vaccine fails to curb the epidemic. An improved vaccination strategy …

The humoral immune response to BCG vaccination

R Tanner, B Villarreal-Ramos… - Frontiers in …, 2019 - frontiersin.org
Bacillus Calmette Guérin (BCG) is the only currently available vaccine against tuberculosis
(TB), but it confers incomplete and variable protection against pulmonary TB in humans and …

Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis

H Li, X Wang, B Wang, L Fu, G Liu… - Proceedings of the …, 2017 - National Acad Sciences
The role of Igs in natural protection against infection by Mycobacterium tuberculosis (Mtb),
the causative agent of TB, is controversial. Although passive immunization with mAbs …

Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis

A Watson, H Li, B Ma, R Weiss, D Bendayan… - Nature …, 2021 - nature.com
Mycobacterium tuberculosis (Mtb) exposure drives antibody responses, but whether patients
with active tuberculosis elicit protective antibodies, and against which antigens, is still …

Clinical manifestations and immune response to tuberculosis

ML Carabalí-Isajar, OH Rodríguez-Bejarano… - World Journal of …, 2023 - Springer
Tuberculosis is a far-reaching, high-impact disease. It is among the top ten causes of death
worldwide caused by a single infectious agent; 1.6 million tuberculosis-related deaths were …

Patients with tuberculosis have a dysfunctional circulating B-cell compartment, which normalizes following successful treatment

SA Joosten, KE van Meijgaarden, F Del Nonno… - PLoS …, 2016 - journals.plos.org
B-cells not only produce immunoglobulins and present antigens to T-cells, but also
additional key roles in the immune system. Current knowledge on the role of B-cells in …

Host defense mechanisms against Mycobacterium tuberculosis

Q Chai, Z Lu, CH Liu - Cellular and Molecular Life Sciences, 2020 - Springer
Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), remains the
leading cause of death worldwide from a single infectious pathogen. Mtb is a paradigmatic …